2020/02/01 by European Food Safety Authority (EFSA) · 1 citation
Agricultural and Biological Sciences · Medicine · #Agricultural safety and regulations #Coffee research and impacts #Food Allergy and Anaphylaxis Research
paper · pdf · doi:10.2903/sp.efsa.2020.en-1783
openalex publication_date 2020/02/01 · openalex created_date 2022/05/12 · openalex updated_date 2026/07/29
Following a notification from AM Breweries (Denmark) submitted to the European Commission under Article 14 of Regulation (EU) 2015/2283 to place on the market an infusion from coffee leaves (Coffea arabica L. and/or Coffea canephora Pierre ex A.Froehner) as a traditional food from a third country (TF), and in line with Article 15(2) of that Regulation, EFSA was asked by the European Commission whether there are duly reasoned safety objections to the placing on the market of the TF within the European Union (EU). The approach of EFSA for the evaluation of TF notifications is based on the EFSA guidance for stakeholders on notifications for authorisation of TF and on the principles described in the relevant existing guidance documents from the EFSA Scientific Committee. EFSA considers that the available data on composition and history of use of the TF do not raise safety concerns. Considering the available data, EFSA does not raise safety objections to the placing on the market of the requested TF [i.e. infusion from coffee leaves (Coffea arabica L. and/or Coffea canephora Pierre ex A.Froehner)] within the EU.